Baldwin DS - Search Results

1

Selective serotonin reuptake inhibitors, post-treatment sexual dysfunction and persistent genital arousal disorder: A systematic review.

Tarchi L, Merola GP, Baccaredda-Boy O, Arganini F, Cassioli E, Rossi E, Maggi M, Baldwin DS, Ricca V, Castellini G. Tarchi L, et al. Among authors: baldwin ds. Pharmacoepidemiol Drug Saf. 2023 Oct;32(10):1053-1067. doi: 10.1002/pds.5653. Epub 2023 Jun 23. Pharmacoepidemiol Drug Saf. 2023. PMID: 37294623 Review.

2

Depression and sexual dysfunction.

Baldwin DS. Baldwin DS. Br Med Bull. 2001;57:81-99. doi: 10.1093/bmb/57.1.81. Br Med Bull. 2001. PMID: 11719925

3

Reduced treatment-emergent sexual dysfunction as a potential target in the development of new antidepressants.

Baldwin DS, Palazzo MC, Masdrakis VG. Baldwin DS, et al. Depress Res Treat. 2013;2013:256841. doi: 10.1155/2013/256841. Epub 2013 Feb 4. Depress Res Treat. 2013. PMID: 23431429 Free PMC article.

4

Serotonin noradrenaline reuptake inhibitors: A new generation of treatment for anxiety disorders.

Baldwin DS. Baldwin DS. Int J Psychiatry Clin Pract. 2006;10 Suppl 2:12-5. doi: 10.1080/13651500600637056. Int J Psychiatry Clin Pract. 2006. PMID: 24921677

5

Lithium and sexual dysfunction: an under-researched area.

Elnazer HY, Sampson A, Baldwin D. Elnazer HY, et al. Hum Psychopharmacol. 2015 Mar;30(2):66-9. doi: 10.1002/hup.2457. Epub 2015 Jan 26. Hum Psychopharmacol. 2015. PMID: 25619161 Review.

6

Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence.

Sinclair JM, Chambers SE, Shiles CJ, Baldwin DS. Sinclair JM, et al. Among authors: baldwin ds. Drug Saf. 2016 Jul;39(7):627-45. doi: 10.1007/s40264-016-0416-y. Drug Saf. 2016. PMID: 27023898 Review.

7

Authors' Reply to Alain Braillon's Comment on "Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence".

Sinclair JM, Chambers SE, Baldwin DS. Sinclair JM, et al. Among authors: baldwin ds. Drug Saf. 2016 Nov;39(11):1153-1154. doi: 10.1007/s40264-016-0448-3. Drug Saf. 2016. PMID: 27503285 No abstract available.

8

Optimal treatment for obsessive compulsive disorder: a randomized controlled feasibility study of the clinical-effectiveness and cost-effectiveness of cognitive-behavioural therapy, selective serotonin reuptake inhibitors and their combination in the management of obsessive compulsive disorder.

Fineberg NA, Baldwin DS, Drummond LM, Wyatt S, Hanson J, Gopi S, Kaur S, Reid J, Marwah V, Sachdev RA, Pampaloni I, Shahper S, Varlakova Y, Mpavaenda D, Manson C, O'Leary C, Irvine K, Monji-Patel D, Shodunke A, Dyer T, Dymond A, Barton G, Wellsted D. Fineberg NA, et al. Among authors: baldwin ds. Int Clin Psychopharmacol. 2018 Nov;33(6):334-348. doi: 10.1097/YIC.0000000000000237. Int Clin Psychopharmacol. 2018. PMID: 30113928 Free PMC article. Clinical Trial.

9

Anxiety in asthma: a systematic review and meta-analysis.

Ye G, Baldwin DS, Hou R. Ye G, et al. Among authors: baldwin ds. Psychol Med. 2021 Jan;51(1):11-20. doi: 10.1017/S0033291720005097. Epub 2021 Jan 12. Psychol Med. 2021. PMID: 33431086

10

Latency to selective serotonin reuptake inhibitor vs benzodiazepine treatment in patients with panic disorder: a naturalistic study.

Piccoli E, Bergamaschini I, Molteni L, Vanzetto S, Varinelli A, Viganò C, Catania G, Baldwin DS, Domschke K, Dell'Osso B. Piccoli E, et al. Among authors: baldwin ds. CNS Spectr. 2023 Feb;28(1):46-52. doi: 10.1017/S1092852921000869. Epub 2021 Nov 5. CNS Spectr. 2023. PMID: 34736545 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

385 results

Search Page